Beth Israel Deaconess Medical Center (Adult Site)

Boston, Massachusetts 02215

0 studies enrolling now · 2 studies all time

What they study most

Covid19, Dermatomyositis, Juvenile Dermatomyositis, Myositis, Polymyositis, SARS-CoV Infection

Studies at this site

• A Study to Evaluate the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to<18 Years) at Risk for SARS-CoV-2 — Completed
• Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM) — Completed